MAST1 and cancer: The inhibition of hsp90 promotes E3 ligase CHIP-mediated ubiquitination of MAST1, resulting in cisplatin sensitization of cancer cells 12 and suggesting that MAST1 protein level is a key factor in circumventing cisplatin-resistance.